Sansure Biotech
Changsha, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A leading Chinese diagnostics company providing testing solutions for infectious diseases and beyond.
DiagnosticsInfectious Disease
Technology Platform
Integrated platform for molecular diagnostics (PCR), immunoassay, and instrument manufacturing for a full suite of IVD solutions.
Opportunities
Significant opportunity to capitalize on China's growing demand for advanced precision diagnostics in oncology, prenatal screening, and chronic disease management.
Risk Factors
Revenue concentration risk from the decline in COVID-19 testing demand and potential pricing pressure from centralized IVD procurement policies in China.
Competitive Landscape
Faces competition from global IVD leaders and a large number of agile domestic Chinese diagnostics companies across multiple testing segments.